Abstract:Introduction Staphylococcus aureus (SA) and Methicillin-resistant Staphylococcus aureus (MRSA) are significant and preventable sources of inflatable penile prosthesis (IPP) infection. SA and MRSA nasal carriers have increased risk of healthcare-related infections. Screening and prompt decolonization for nasal carriers of SA in the hospital setting has been shown to reduce postoperative SA hospital-associated surgical-site infections. Objective We determined if known epidemiologic risk factors for SA and MRSA were prevalent in our IPP patients who tested positive for SA or MRSA at their preoperative visit. Our hypothesis was that these determinants would help identify at-risk patients to better target preoperative SA and MRSA screening in the future. Methods This is a retrospective IRB-approved analysis of 62 asymptomatic patients who screened positive for either SA (n = 56) or MRSA (n = 6) via nasal culture prior to undergoing IPP placement at two hospitals in our practice. These two groups were evaluated separately to compare the presence of risk factors present for SA and MRSA prior to nasal screening. Known risk factors for SA include: intravenous drug use, diabetes, recent hospitalization within 30 days, immunocompromised status, healthcare employment, hemodialysis, HIV positive status, and prior prosthetic implant placement. Known risk factors for MRSA patients include: intravenous drug use, living in a correctional facility, residential home, or shelter, occupation as a veterinarian, recent influenza-like illness and/or severe pneumonia, concurrent skin/soft tissue infection, and history of MRSA. We examined the presence of these risk factors in patients who screened positive for nasal colonization to determine if they could have undergone targeted nasal screening. Results Our data are shown in Table 1. We found that the most common indicator for SA colonization in our population was diabetes in 16 of 56 patients (28.6%). We found the most common MRSA-specific risk factor was a history of MRSA in 1 of 6 patients (16.7%). No patient in this prescreened and pretreated cohort subsequently had IPP infection. Conclusions No known risk factor for SA and MRSA colonization was found to be widely prevalent in our SA and MRSA patient cohorts. Targeting screening based on known epidemiologic risk factors for SA and MRSA would not have been a useful substitute for universal preoperative nasal screening in our population. Universal preoperative nasal SA and MRSA screening and treatment may be a useful tool to potentially diminish postoperative IPP surgical-site infections. Disclosure Any of the authors act as a consultant, employee or shareholder of an industry for: Coloplast, MenMD.

Assessing the Predictive Value of Methicillin-Resistant Staphylococcus aureus Nares Colonization Among Transplant Recipients and Patients With Neutropenia

MRSA nasal screening predictive values assessment in patients with osteomyelitis

Evaluation of methicillin-resistant Staphylococcus aureus nasal swab screening at a large comprehensive cancer center

167. Duration of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares PCR Positivity while Receiving Highly Active Anti-Staphylococcal Drugs

The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis With Antimicrobial Stewardship Implications

Persistent Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Test Positivity During Initial Days of Systemic Anti-Staphylococcal Antimicrobial Therapy

513 Predictive Values of MRSA Nasal Swabs for Pneumonia in Burn ICU Patients

Predictive values of methicillin-resistant Staphylococcus aureus nasal swabs for pneumonia in burn ICU patients

Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Real-Time PCR: A Predictive Tool for Contamination of the Hospital Environment

Evaluation of Gram Stain-Guided Antibiotic Therapy for Methicillin-Resistant Staphylococcus aureus Pneumonia in Intensive Care Unit Patients

Pediatric Clinical Outcomes of Nasal Methicillin-resistant Staphylococcus aureus Polymerase Chain Reaction Utilization

Utility of MRSA nares PCR for non-respiratory cultures in critically ill patients: an observational evaluation

Evaluating the Diagnostic Performance of Nasal Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction in Hospital-Acquired Pneumonia Within the Intensive Care Unit. A Retrospective Study

(163) VIABILITY OF TARGETED SCREENING FOR STAPHYLOCOCCUS AUREUS AND MRSA AS A SUBSTITUTE FOR UNIVERSAL PREOPERATIVE INFLATABLE PENILE PROSTHESIS NASAL SCREENING

Antibiotic de-escalation in pneumonia with pharmacist education and ordering of methicillin-resistant Staphylococcus aureus nasal swabs

Utility of methicillin-resistant Staphylococcus aureus nasal PCR testing in pediatric patients with suspected respiratory infections

Rapid de-escalation of anti-MRSA therapy guided by S. aureus nares screening for patients with pneumonia: protocol of a randomized controlled trial (SNAP study)

Comparison of screening for methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission and discharge

Evaluation and use of a rapid Staphylococcus aureus assay by an antimicrobial stewardship program

The impact of a "search and destroy" strategy for the prevention of methicillin-resistant Staphylococcus aureus infections in an inpatient rehabilitation facility

Everybody nose: molecular and clinical characteristics of nasal colonization during active methicillin-resistant Staphylococcus aureus bloodstream infection